DC Field | Value | Language |
---|---|---|
dc.contributor.author | Choi, Byong-Seok | ko |
dc.contributor.author | Kang, Suk-Jo | ko |
dc.contributor.author | Lee, Janghyun | ko |
dc.contributor.author | Min, Ji Youn | ko |
dc.contributor.author | Chun, Dongmin | ko |
dc.contributor.author | Sung, Si-Eun | ko |
dc.date.accessioned | 2020-12-11T00:10:19Z | - |
dc.date.available | 2020-12-11T00:10:19Z | - |
dc.identifier.uri | http://hdl.handle.net/10203/278193 | - |
dc.description.abstract | The present disclosure provides a pharmaceutical composition for treating cancer comprising an RNA oligonucleotide having a particular sequence and structure. Specifically, when a cell line is treated with an RNA oligonucleotide having specific sequence and helical bend structure according to the present disclosure, the expression of ISG56 is increased and apoptosis of cancer cells is induced. Thus, a composition comprising the RNA oligonucleotide can be used as an anticancer agent. | - |
dc.title | PHARMACEUTICAL COMPOSITION FOR TREATMENT OF CANCER COMPRISING RNA | - |
dc.title.alternative | RNA 올리고뉴클레오티드를 포함하는 암 치료용 약학 조성물 | - |
dc.type | Patent | - |
dc.type.rims | PAT | - |
dc.contributor.localauthor | Choi, Byong-Seok | - |
dc.contributor.localauthor | Kang, Suk-Jo | - |
dc.contributor.assignee | KAIST | - |
dc.identifier.iprsType | 특허 | - |
dc.identifier.patentApplicationNumber | 16855780.9 | - |
dc.identifier.patentRegistrationNumber | 3363464 | - |
dc.date.application | 2016-10-14 | - |
dc.date.registration | 2020-03-18 | - |
dc.publisher.country | FR | - |
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.